Literature DB >> 27773356

Polycystic ovary syndrome and endometrial hyperplasia: an overview of the role of bariatric surgery in female fertility.

Vasileios Charalampakis1, Abd A Tahrani2, Ahmed Helmy3, Janesh K Gupta4, Rishi Singhal5.   

Abstract

One of the most effective methods to tackle obesity and its related comorbidities is bariatric surgery. Polycystic ovary syndrome (PCOS) and endometrial hyperplasia (EH), which are associated with increased risk of endometrial carcinoma, have been identified as potentially new indications for bariatric surgery. PCOS is the most common endocrine disorder in women in the reproductive age and is associated with several components of the metabolic syndrome such as obesity, insulin resistance and hypertension. EH is a pre-cancerous condition which arises in the presence of chronic exposure to estrogen unopposed by progesterone such as both in PCOS and obesity. The main bariatric procedures are Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. These procedures are well established and when correctly selected and performed by experienced bariatric surgeons, they can achieve significant weight loss and remission of obesity related co-morbidities. Studies have shown that bariatric surgery can play an important role in the management of patients with PCOS and improve fertility. Similarly, bariatric surgery has a positive effect on endometrial hyperplasia, making surgically induced weight loss a potentially attractive option for endometrial cancer prevention and treatment. Obesity has an adverse impact on spontaneous pregnancy, assisted reproduction methods and feto-maternal outcomes. After bariatric surgery obese women with subfertility can achieve spontaneous pregnancy. However, while bariatric surgery reduces the risk of pre-eclampsia and gestational diabetes, there is an increased risk of small for gestational age and possible increased risk of stillborn or neonatal death. In this article we will review the evidence regarding the use of bariatric surgery as a treatment modality in patients with PCOS and EH. We also provide an overview of the common bariatric procedures.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Endometrial hyperplasia; Obesity; Polycystic ovary syndrome

Mesh:

Year:  2016        PMID: 27773356     DOI: 10.1016/j.ejogrb.2016.10.001

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  14 in total

1.  Patterns of Bariatric Surgeries Among U.S. Women Diagnosed with Polycystic Ovarian Syndrome.

Authors:  Hind A Beydoun; May A Beydoun; Sharmin Hossain; Laurel Stadtmauer; Shaker M Eid; Alan B Zonderman
Journal:  J Womens Health (Larchmt)       Date:  2020-02-20       Impact factor: 2.681

2.  Microbial Reconstitution Reverses Early Female Puberty Induced by Maternal High-fat Diet During Lactation.

Authors:  Mengjie Wang; Youjie Zhang; David Miller; Naveen O Rehman; Xi Cheng; Ji-Youn Yeo; Bina Joe; Jennifer W Hill
Journal:  Endocrinology       Date:  2020-02-01       Impact factor: 4.736

3.  The Effect of Sleeve Gastrectomy on the Hormonal Profile of Patients with Polycystic Ovary Syndrome.

Authors:  Agostinho S Machado Júnior; Cláudio B L Ribeiro; Fernando Santa-Cruz; Brena F Sena; Jose-Luiz Figueiredo; Álvaro A B Ferraz; Josemberg M Campos
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

4.  Review: Sex-Specific Aspects in the Bariatric Treatment of Severely Obese Women.

Authors:  Pia Jäger; Annina Wolicki; Johannes Spohnholz; Metin Senkal
Journal:  Int J Environ Res Public Health       Date:  2020-04-15       Impact factor: 3.390

5.  Are patients aware of potential risks of weight reduction surgery? An internet based survey.

Authors:  Abdullah A Alamri; Abdulrahman I Alsadiqi; Abdulwahab Dahlawi; Ahmad Alghamdi; Majed Alnefaie; Mohammed Alhazmi; Omar Tewfik; Adel Almaymuni; Hatim Al-Abbadi; Mahmoud Mosli
Journal:  Saudi J Gastroenterol       Date:  2019 Mar-Apr       Impact factor: 2.485

6.  Obese and Non-obese Polycystic Ovarian Syndrome: Comparison of Clinical, Metabolic, Hormonal Parameters, and their Differential Response to Clomiphene.

Authors:  Garima Sachdeva; Shalini Gainder; Vanita Suri; Naresh Sachdeva; Seema Chopra
Journal:  Indian J Endocrinol Metab       Date:  2019 Mar-Apr

7.  Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study.

Authors:  Balachandran Kumarendran; Dana Sumilo; Michael W O'Reilly; Konstantinos A Toulis; Krishna M Gokhale; Chandrika N Wijeyaratne; Arri Coomarasamy; Wiebke Arlt; Abd A Tahrani; Krishnarajah Nirantharakumar
Journal:  Eur J Endocrinol       Date:  2019-04       Impact factor: 6.664

8.  Scaffold-Free Endometrial Organoids Respond to Excess Androgens Associated With Polycystic Ovarian Syndrome.

Authors:  Teerawat Wiwatpanit; Alina R Murphy; Zhenxiao Lu; Margrit Urbanek; Joanna E Burdette; Teresa K Woodruff; J Julie Kim
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

9.  Male sexual function after weight-loss surgeries in a group of Saudi population.

Authors:  Hossam S El-Tholoth; Abdalatiff K Bedaiwi; Abdulrahman Binjawhar; Ahmed A Almulhem; Khaled K Bedaiwi; Haider Alshurafa; Tarek Alzahrani; Ruyof K Alhussein; Abdulaziz K Alhussein; Mussa Alnumi
Journal:  Urol Ann       Date:  2021-03-04

10.  A Comparison of a Pulse-Based Diet and the Therapeutic Lifestyle Changes Diet in Combination with Exercise and Health Counselling on the Cardio-Metabolic Risk Profile in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial.

Authors:  Maryam Kazemi; Laura E McBreairty; Donna R Chizen; Roger A Pierson; Philip D Chilibeck; Gordon A Zello
Journal:  Nutrients       Date:  2018-09-30       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.